Literature DB >> 9845968

Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis.

A E Medvedev1, A V Veselovsky, V I Shvedov, O V Tikhonova, T A Moskvitina, O A Fedotova, L N Axenova, N S Kamyshanskaya, A Z Kirkel, A S Ivanov.   

Abstract

A series of pyrazinocarbazoles, analogues of short acting antidepressant pirlindole (2,3,3a,4,5,6-hexahydro-8-methyl-1H-pyrazino[3,2,1-j,k]carbazole hydrochloride), were tested as inhibitors of monoamine oxidase A (MAO-A) and B (MAO-B). Rigid analogues exhibited potent and selective inhibition of MAO-A and have size limits (X:Y:Z) of 13.0 x 7.0 x 4.4 A. Besides MAO-A inhibition flexible analogues also demonstrated potent inhibition of MAO-B and in contrast to rigid analogues their inhibitory activity did not show the dependence on these sizes. The qualitative information (steric and electrostatic coefficients) from the 3D-QSAR with CoMFA models for MAO-A and -B are different, and this information can be used to determine the structural features influencing inhibitor selectivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9845968     DOI: 10.1021/ci9802068

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  8 in total

1.  Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines--a QSAR study.

Authors:  Gabriel Vallejos; Marcos Caroli Rezende; Bruce K Cassels
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

Review 2.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  An MCASE approach to the search of a cure for Parkinson's Disease.

Authors:  Gilles Klopman; Aleksandr Sedykh
Journal:  BMC Pharmacol       Date:  2002-04-02

4.  Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases.

Authors:  Wolfgang Link; Julen Oyarzabal; Beatriz G Serelde; Maria Isabel Albarran; Obdulia Rabal; Antonio Cebriá; Patricia Alfonso; Jesus Fominaya; Oliver Renner; Sandra Peregrina; David Soilán; Plácido A Ceballos; Ana-Isabel Hernández; Milagros Lorenzo; Paolo Pevarello; Teresa G Granda; Guido Kurz; Amancio Carnero; James R Bischoff
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

5.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.

Authors:  R R Ramsay; C Dunford; P K Gillman
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

6.  Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors.

Authors:  Alexei E Medvedev; Alexis S Ivanov; Alexander V Veselovsky
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

7.  Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C.

Authors:  Rachel Ulferts; S Matthijn de Boer; Lonneke van der Linden; Lisa Bauer; Hey Rhyoung Lyoo; Maria J Maté; Julie Lichière; Bruno Canard; Daphne Lelieveld; Wienand Omta; David Egan; Bruno Coutard; Frank J M van Kuppeveld
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 8.  Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.

Authors:  Reem Aljanabi; Lina Alsous; Dima A Sabbah; Halise Inci Gul; Mustafa Gul; Sanaa K Bardaweel
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.